Ami Organics Limited Cash Flow Conversion Efficiency

Latest as of September 2023: 0.087x

Ami Organics Limited cash flow conversion efficiency. Based on the latest financial reports, Ami Organics Limited (AMIORG) has a cash flow conversion efficiency ratio of 0.087x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs558.65 Million ≈ $6.04 Million USD) by net assets (Rs6.45 Billion ≈ $69.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ami Organics Limited (2014–2025)

Cash flow conversion efficiency of Ami Organics Limited from 2014 to 2025. This chart illustrates how Ami Organics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ami Organics Limited (AMIORG) stock price for real-time trading data and today's change.

Ami Organics Limited Cash Flow Conversion Ratio Explained

Ami Organics Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ami Organics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ami Organics Limited ranked by their cash flow conversion efficiency. Also see AMIORG company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Xinjiang Communications Construction Group Co Ltd Class A
SHE:002941
0.089x
Xpel Inc
NASDAQ:XPEL
0.121x
He Bei Cheng De LoLo Co Ltd
SHE:000848
0.076x
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645
0.028x
Jinfu Technology Co Ltd
SHE:003018
0.066x
PCBL LIMITED
NSE:PCBL
0.205x
TRUSTPILOT GROUP LS -01
F:6VZ
N/A
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
N/A

Annual Cash Flow Conversion Efficiency for Ami Organics Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Ami Organics Limited from 2014 to 2025. Review AMIORG free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs13.20 Billion
≈ $142.76 Million
Rs1.18 Billion
≈ $12.80 Million
0.090x -51.10%
2024-03-31 Rs6.83 Billion
≈ $73.84 Million
Rs1.25 Billion
≈ $13.54 Million
0.183x +66.17%
2023-03-31 Rs5.94 Billion
≈ $64.23 Million
Rs655.30 Million
≈ $7.09 Million
0.110x +765.36%
2022-03-31 Rs5.22 Billion
≈ $56.48 Million
Rs-86.60 Million
≈ $-936.56K
-0.017x -110.20%
2021-03-31 Rs1.67 Billion
≈ $18.05 Million
Rs271.45 Million
≈ $2.94 Million
0.163x -32.85%
2020-03-31 Rs1.12 Billion
≈ $12.09 Million
Rs270.77 Million
≈ $2.93 Million
0.242x +34.18%
2019-03-31 Rs822.19 Million
≈ $8.89 Million
Rs148.38 Million
≈ $1.60 Million
0.180x +86.49%
2018-03-31 Rs576.82 Million
≈ $6.24 Million
Rs55.82 Million
≈ $603.67K
0.097x -85.12%
2017-03-31 Rs389.92 Million
≈ $4.22 Million
Rs253.64 Million
≈ $2.74 Million
0.650x +140.00%
2016-03-31 Rs274.24 Million
≈ $2.97 Million
Rs74.33 Million
≈ $803.85K
0.271x +174.08%
2015-03-31 Rs148.31 Million
≈ $1.60 Million
Rs-54.26 Million
≈ $-586.80K
-0.366x -134.05%
2014-03-31 Rs107.73 Million
≈ $1.17 Million
Rs-16.84 Million
≈ $-182.12K
-0.156x --

About Ami Organics Limited

NSE:AMIORG India Specialty Chemicals
Market Cap
$1.18 Billion
Rs108.67 Billion INR
Market Cap Rank
#7929 Global
#392 in India
Share Price
Rs1327.40
Change (1 day)
+0.00%
52-Week Range
Rs1327.40 - Rs1327.40
All Time High
Rs2626.70
About

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more